ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.665
      -0.14%
      Bitcoin
      65,081.64
      -0.09%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      12/30/20216:38PMGlobeNewswire Inc.Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host DiseaseNASDAQ:MESOMesoblast Limited
      12/17/20216:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      12/15/20217:09PMGlobeNewswire Inc.FDA’s OTAT in Agreement With 12-Month Reduction in Pain as Primary Endpoint for Chronic Low Back Pain ProgramNASDAQ:MESOMesoblast Limited
      12/14/20216:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      12/13/20217:18PMGlobeNewswire Inc.Update on Novartis AgreementNASDAQ:MESOMesoblast Limited
      12/07/20216:13AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      12/05/20216:47PMGlobeNewswire Inc.Rexlemestrocel-L Shows Greatest Treatment Benefit on Major Adverse Cardiovascular Events in High-Risk Heart Failure Patients With Diabetes and/or Myocardial IschemiaNASDAQ:MESOMesoblast Limited
      12/02/20216:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      11/26/20216:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      11/23/20216:09PMGlobeNewswire Inc.Operational Highlights and Financial Results for the Period Ended September 30, 2021NASDAQ:MESOMesoblast Limited
      11/23/20217:18AMGlobeNewswire Inc.Mesoblast Corporate Update and Financial Results WebcastNASDAQ:MESOMesoblast Limited
      11/21/20217:31PMGlobeNewswire Inc.Mesoblast and Oaktree Capital Enter Into Refinancing and Expansion of Senior Debt FacilityNASDAQ:MESOMesoblast Limited
      11/14/20217:13PMGlobeNewswire Inc.Late Breaking Presentation at American Heart Association Annual Meeting of Landmark Phase 3 Trial of Rexlemestrocel-L in Chronic Heart FailureNASDAQ:MESOMesoblast Limited
      11/04/20216:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      10/28/20217:51PMGlobeNewswire Inc.Appendix 4C Quarterly Activity ReportNASDAQ:MESOMesoblast Limited
      10/19/20216:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      10/18/20218:00AMGlobeNewswire Inc.Remestemcel-L Improves Survival of Children With Biomarkers for Highest Mortality in Steroid Refractory Acute GVHDNASDAQ:MESOMesoblast Limited
      10/08/20216:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      10/06/20218:38PMGlobeNewswire Inc.Rexlemestrocel-L Phase 3 Trial Results in Chronic Heart Failure Selected as Late Breaking Presentation at American Heart Association Annual MeetingNASDAQ:MESOMesoblast Limited
      09/01/20216:09AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      08/31/20217:50AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:MESOMesoblast Limited
      08/30/20217:38PMGlobeNewswire Inc.Operational Highlights and Financial Results for the Year Ended June 30, 2021NASDAQ:MESOMesoblast Limited
      08/30/20218:00AMGlobeNewswire Inc.Mesoblast Corporate Update and Financial Results WebcastNASDAQ:MESOMesoblast Limited
      08/13/20216:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      07/29/20218:06PMGlobeNewswire Inc.Appendix 4C Quarterly Activity ReportNASDAQ:MESOMesoblast Limited
      07/21/20216:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      07/18/20218:58PMGlobeNewswire Inc.Ninety Day Survival Outcomes in COVID-19 ARDS Trial of Remestemcel-L Presented at ISCT Meeting on Advances in Cell & Gene The...NASDAQ:MESOMesoblast Limited
      07/15/20218:15PMGlobeNewswire Inc.Mesoblast Presents Respiratory Function Results of COVID-19 ARDS Trial at Pulmonary Disease ConferenceNASDAQ:MESOMesoblast Limited
      07/09/20217:46AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
      07/02/20216:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO